We have limited Portuguese content available. View Portuguese content.

Infographic

Despite Tough Year, Outlook Is Strong for M&A in Pharma and Biotech

After a year in which deal value fell across the healthcare sector, pharma and biotech companies are poised for an active 2021.

Infographic

Despite Tough Year, Outlook Is Strong for M&A in Pharma and Biotech
en
Read more

Getting Ready for the Recovery in Healthcare M&A

Companies willing to invest shrewdly in the downturn will emerge from it stronger.
Explore the full report

M&A Report 2022

Bain's fourth annual Global M&A Report looks at what the best companies did to win in a white-hot market.
Tags

How We've Helped Clients

Divestiture adds value to parent, subsidiary

See more related case studies

Recharging the pharmaceutical sales model

See more related case studies

A healthcare giant overcomes merger risks for global growth

See more related case studies

Quer saber mais?

Ajudamos líderes do mundo todo a lidar com desafios e oportunidades cruciais para sua organização. Juntos, criamos mudanças e resultados duradouros

Contact Bain

How can we help you?

See all offices